SK3782002A3 - 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same - Google Patents

4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same Download PDF

Info

Publication number
SK3782002A3
SK3782002A3 SK378-2002A SK3782002A SK3782002A3 SK 3782002 A3 SK3782002 A3 SK 3782002A3 SK 3782002 A SK3782002 A SK 3782002A SK 3782002 A3 SK3782002 A3 SK 3782002A3
Authority
SK
Slovakia
Prior art keywords
dihydro
pyrrol
morpholin
group
dihydropyrrol
Prior art date
Application number
SK378-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas Arnold
Klaus Unverferth
Hans-Joachim Lankau
Angelika Rostock
Christine Tober
Chris Runfeldt
Reni Bartsch
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of SK3782002A3 publication Critical patent/SK3782002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK378-2002A 1999-09-16 2000-09-02 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same SK3782002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944332A DE19944332A1 (de) 1999-09-16 1999-09-16 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung
PCT/EP2000/008572 WO2001019793A1 (de) 1999-09-16 2000-09-02 Antikonvulsiv und anxiolytisch wirkende 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one und verfahren zu deren darstellung

Publications (1)

Publication Number Publication Date
SK3782002A3 true SK3782002A3 (en) 2002-07-02

Family

ID=7922190

Family Applications (1)

Application Number Title Priority Date Filing Date
SK378-2002A SK3782002A3 (en) 1999-09-16 2000-09-02 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same

Country Status (20)

Country Link
US (1) US6500821B1 (de)
EP (1) EP1212297A1 (de)
JP (1) JP2003509407A (de)
KR (1) KR20020027657A (de)
CN (1) CN1374948A (de)
AR (1) AR025700A1 (de)
AU (1) AU7283000A (de)
BG (1) BG106437A (de)
BR (1) BR0013961A (de)
CA (1) CA2317257A1 (de)
CZ (1) CZ2002915A3 (de)
DE (1) DE19944332A1 (de)
EE (1) EE200200137A (de)
HU (1) HUP0202607A3 (de)
IL (1) IL147808A0 (de)
MX (1) MXPA02001370A (de)
NO (1) NO20021143L (de)
SK (1) SK3782002A3 (de)
TR (1) TR200200678T2 (de)
WO (1) WO2001019793A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106008304B (zh) * 2016-05-18 2018-07-17 湖北科技学院 一种1,3-二氢吡咯-2-酮类化合物及其合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543504A (de) * 1971-03-25 1973-10-31 Lonza Ag Verfahren zur Herstellung 1-substituierter 4-Aminopyrrolin-3-one-(2)
US4511568A (en) 1982-05-12 1985-04-16 Ici Americas Inc. CNS-Depressant pyrazolopyridines

Also Published As

Publication number Publication date
HUP0202607A3 (en) 2003-05-28
NO20021143D0 (no) 2002-03-07
EE200200137A (et) 2003-04-15
WO2001019793A1 (de) 2001-03-22
NO20021143L (no) 2002-03-07
MXPA02001370A (es) 2004-09-10
JP2003509407A (ja) 2003-03-11
DE19944332A1 (de) 2001-03-22
BR0013961A (pt) 2002-05-21
US6500821B1 (en) 2002-12-31
BG106437A (bg) 2002-09-30
TR200200678T2 (tr) 2002-07-22
AU7283000A (en) 2001-04-17
KR20020027657A (ko) 2002-04-13
CA2317257A1 (en) 2001-03-16
EP1212297A1 (de) 2002-06-12
CN1374948A (zh) 2002-10-16
IL147808A0 (en) 2002-08-14
AR025700A1 (es) 2002-12-11
HUP0202607A2 (hu) 2002-12-28
CZ2002915A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
KR0135969B1 (ko) 아릴(또는 헤테로아릴) 피페라지닐알킬아졸 유도체 및 그의 제조방법 및 그의 의약품으로의 이용
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US5589486A (en) N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives
EP1948662A2 (de) Als oxytocinrezeptorantagonisten geeignete tricyclische verbindungen
US5565455A (en) Method for treating substance abuse disorders
US4284555A (en) 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
DE2733817A1 (de) 2-benzylpyrrolidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
KR100444697B1 (ko) 피리도티아진유도체및이를포함하는약제학적조성물
SK3782002A3 (en) 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same
UA44838C2 (uk) Спосіб лікування мігрені
DE3503074A1 (de) Hydantoinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
US6221858B1 (en) Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
US5994347A (en) For a process for treatment of anxiety and tension
US4514403A (en) Hydrouracil compounds
US5180726A (en) 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinylalkyl substituted lactams
FI63023C (fi) Foerfarande foer framstaellning av smaertlindrande 4-amino-trans-dekahydrokinolinderivat
DE69911436T2 (de) Die verwendung von r (+)- g(a)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol zur behandlung von obstruktive schlafapnoe
WO1998055125A1 (en) Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
RO115725B1 (ro) Esteri ai acidului nicotinic, procedee de preparare, compozitie care ii contine, si metoda de tratament
US4007272A (en) Substituted benzodiazepin-10-ones in treating pain and depression
KR20020015321A (ko) 신경 세포사 억제제
JPH05194235A (ja) 中枢性カルシウム拮抗剤
KR20010012884A (ko) 불안 및 스트레스 상태의 치료를 위한1-아르(알크)일이미다졸린-2-온의 용도
DE19521932A1 (de) Neue Verwendung von Glutamat-Antagonisten
IE913211A1 (en) Use of n-(1-hexahydroazepinylalkyl) acetamides in the¹preparation of medicaments for the treatment of cholinergic¹transmission disorders